S T Chari

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer
    Raghuram P Reddy
    Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 2:1026-31. 2004
  2. ncbi Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA
    J Gastroenterol 42:39-41. 2007
  3. ncbi Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
    Amaar Ghazale
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastroenterology 134:706-15. 2008
  4. ncbi Diabetes and pancreatic cancer
    T Muniraj
    Yale University School of Medicine, New Haven, CT, USA
    Minerva Gastroenterol Dietol 58:331-45. 2012
  5. ncbi Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer
    S T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastroenterology 121:640-5. 2001
  6. ncbi Probability of pancreatic cancer following diabetes: a population-based study
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Rochester, Minnesota 55905, USA
    Gastroenterology 129:504-11. 2005
  7. ncbi Is magnetic resonance cholangiography of clinical value in the diagnosis and treatment of gallstone pancreatitis?
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Nat Clin Pract Gastroenterol Hepatol 2:170-1. 2005
  8. ncbi A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer
    Suresh T Chari
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 7:1097-103. 2009
  9. ncbi Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer
    Suresh T Chari
    Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastroenterology 134:95-101. 2008
  10. ncbi Detecting early pancreatic cancer: problems and prospects
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Semin Oncol 34:284-94. 2007

Research Grants

  1. Does Hyperglycemia Predict Pancreatic Cancer Diagnosis?
    Suresh Chari; Fiscal Year: 2006

Detail Information

Publications83

  1. ncbi Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer
    Raghuram P Reddy
    Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 2:1026-31. 2004
    ..These observations suggest that ovarian stroma should be used as the defining criterion for diagnosing MCN...
  2. ncbi Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA
    J Gastroenterol 42:39-41. 2007
    ..A combination of the HISORt criteria can be used to definitively diagnose a wide spectrum of manifestations of AIP...
  3. ncbi Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
    Amaar Ghazale
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastroenterology 134:706-15. 2008
    ..We describe clinical features, treatment response, and predictors of relapse in IAC and compare relapse rates in IAC with intrapancreatic vs proximal bile duct strictures...
  4. ncbi Diabetes and pancreatic cancer
    T Muniraj
    Yale University School of Medicine, New Haven, CT, USA
    Minerva Gastroenterol Dietol 58:331-45. 2012
    ..However, to screen new-onset diabetes for pancreatic cancer, additional markers are needed that can distinguish pancreatic cancer-associated diabetes from type 2 diabetes...
  5. ncbi Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer
    S T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastroenterology 121:640-5. 2001
    ....
  6. ncbi Probability of pancreatic cancer following diabetes: a population-based study
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Rochester, Minnesota 55905, USA
    Gastroenterology 129:504-11. 2005
    ..Although diabetes occurs frequently in pancreatic cancer, the value of new-onset diabetes as a marker of underlying pancreatic cancer is unknown...
  7. ncbi Is magnetic resonance cholangiography of clinical value in the diagnosis and treatment of gallstone pancreatitis?
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Nat Clin Pract Gastroenterol Hepatol 2:170-1. 2005
  8. ncbi A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer
    Suresh T Chari
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 7:1097-103. 2009
    ..Autoimmune pancreatitis (AIP) and pancreatic cancer (PaC) have similar presentations; a diagnostic strategy is needed to distinguish the 2 diseases...
  9. ncbi Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer
    Suresh T Chari
    Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastroenterology 134:95-101. 2008
    ..The temporal association between diabetes mellitus and pancreatic cancer is poorly understood. We compared temporal patterns in diabetes prevalence in pancreatic cancer and controls...
  10. ncbi Detecting early pancreatic cancer: problems and prospects
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Semin Oncol 34:284-94. 2007
    ..Although much work still needs to be done, the developments in the field provide us with hope that screening for early pancreatic cancer could become a reality in the not-so-distant future...
  11. ncbi Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document
    Suresh T Chari
    Mayo Clinic, Rochester, MN, USA
    Pancreas 39:549-54. 2010
    ..Whereas most experts agreed that the entities should be referred to as type 1 and type 2 AIP, respectively, others had concerns regarding use of the term "autoimmune" to describe IDCP...
  12. ncbi Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document
    Suresh T Chari
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Pancreatology 10:664-72. 2010
    ..While most experts agreed that the entities should be referred to as type 1 and type 2 AIP, respectively, others had concerns regarding use of the term 'autoimmune' to describe IDCP. and IAP...
  13. ncbi Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastroenterology 123:1500-7. 2002
    ....
  14. ncbi Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Pancreatology 5:229-33. 2005
    ..To gain insights into pathogenesis of pancreatic cancer-associated diabetes...
  15. ncbi Branch duct intraductal papillary mucinous neoplasm of the pancreas in solid organ transplant recipients
    Kanwar Rupinder S Gill
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida 32224, USA
    Am J Gastroenterol 104:1256-61. 2009
    ..Recent studies show that IPMN-Br without consensus indications for resection (CIR) can be followed conservatively. We analyzed the course of IPMN-Br in patients with and without solid organ transplant...
  16. ncbi Disconnected pancreatic duct syndrome in severe acute pancreatitis: clinical and imaging characteristics and outcomes in a cohort of 31 cases
    Mario Pelaez-Luna
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Gastrointest Endosc 68:91-7. 2008
    ..Information regarding the natural history, clinical characteristics, and outcomes of disconnected pancreatic duct syndrome (DPDS) is limited...
  17. ncbi IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis
    Lizhi Zhang
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Mod Pathol 20:23-8. 2007
    ..We rarely see IgG4 staining in patients with chronic alcoholic pancreatitis and pancreatic ductal adenocarcinoma. IgG4-positive plasma cells are a useful marker for the tissue diagnosis of autoimmune pancreatitis...
  18. ncbi Update on the diagnosis and treatment of autoimmune pancreatitis
    Amaar H Ghazale
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Curr Gastroenterol Rep 10:115-21. 2008
    ..This in turn has resulted in the avoidance of unnecessary surgical procedures for suspected malignancy. This article reviews recent updates in the diagnosis and treatment of autoimmune pancreatitis...
  19. ncbi Misdiagnosis of autoimmune pancreatitis: a caution to clinicians
    Timothy B Gardner
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 104:1620-3. 2009
    ..Our purpose is to highlight this growing clinical problem and to reinforce the use of published guidelines for the diagnosis and management of AIP...
  20. ncbi Autoimmune pancreatitis
    Rahul Pannala
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Curr Opin Gastroenterol 24:591-6. 2008
    ..Autoimmune pancreatitis (AIP) is an increasingly recognized clinical condition. Our objective is to provide a concise review of the advances in the past year in our understanding of AIP...
  21. ncbi Dual-phase CT of autoimmune pancreatitis: a multireader study
    Naoki Takahashi
    Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    AJR Am J Roentgenol 190:280-6. 2008
    ..The purpose of this study was to identify findings that aid in differentiating autoimmune pancreatitis from pancreatic carcinoma using dual-phase CT...
  22. ncbi Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block
    Michael J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Gastroenterol 103:98-103. 2008
    ..The recent recognition that celiac ganglia can be visualized by endoscopic ultrasound (EUS) now allows direct injection into celiac ganglia for neurolysis (CGN) and block (CGB)...
  23. ncbi Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis
    Mario Pelaez Luna
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Gastroenterol 102:2157-63. 2007
    ..It is unclear if the cancer is resectable at the onset of diabetes. We (a) determined the resectability of pancreatic cancer on abdominal CT scans done prior to clinical diagnosis and (b) correlated resectability with onset of diabetes...
  24. ncbi Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT
    Naoki Takahashi
    Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    AJR Am J Roentgenol 193:479-84. 2009
    ..The purposes of this study were to define the pancreatic enhancement of autoimmune pancreatitis at dual-phase CT and to compare it with that of pancreatic carcinoma and a normal pancreas...
  25. ncbi Diagnosis and treatment of autoimmune pancreatitis
    Aravind Sugumar
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55901, USA
    Curr Opin Gastroenterol 26:513-8. 2010
    ..To summarize the existing knowledge of autoimmune pancreatitis (AIP) and to review the progress made in the diagnosis and treatment of AIP in the past year...
  26. ncbi The effect of age on hospital outcomes in severe acute pancreatitis
    Timothy B Gardner
    Pancreas Clinic, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minn, USA
    Pancreatology 8:265-70. 2008
    ..We evaluated clinical outcomes, including in-hospital mortality and long-term disease stigmata, in elderly patients admitted with severe acute pancreatitis...
  27. ncbi Calcifying obstructive pancreatitis: a study of intraductal papillary mucinous neoplasm associated with pancreatic calcification
    Mauricio Zapiach
    Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 2:57-63. 2004
    ....
  28. ncbi Autoimmune pancreatitis
    Luis P Lara
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Curr Gastroenterol Rep 7:101-6. 2005
    ..Here we review the clinical, serologic, radiologic, and histologic features of autoimmune pancreatitis...
  29. ncbi Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer
    Amaar Ghazale
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 102:1646-53. 2007
    ..To determine the sensitivity and specificity of elevated serum IgG4 level for the diagnosis of autoimmune pancreatitis (AIP) and its ability to distinguish AIP from pancreatic cancer, its main differential diagnosis...
  30. ncbi Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include "moderately severe acute pancreatitis"
    Santhi Swaroop Vege
    Department of Medicine, Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 104:710-5. 2009
    ..Organ failure (OF) is a main cause of death in severe acute pancreatitis (SAP). Our primary aim was to evaluate the morbidity and mortality of patients admitted with SAP with no OF (NOF), single OF (SOF), and multiple (> or =2) OF (MOF)...
  31. ncbi Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma
    Naoki Takahashi
    Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
    Pancreas 38:523-6. 2009
    ..IgG4-associated systemic disease (ISD) is a multiorgan fibroinflammatory disorder whose pancreatic manifestation is called autoimmune pancreatitis (AIP). We describe 3 patients who developed non-Hodgkin lymphoma during the follow-up of ISD...
  32. ncbi Endoscopic ultrasound-guided trucut biopsy of the cyst wall for diagnosing cystic pancreatic tumors
    Michael J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic School of Medicine, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 3:974-9. 2005
    ..The aim of this study was to determine whether the tissue obtained by endoscopic ultrasound-guided trucut biopsy (EUS TCB) is sufficient for histologic diagnosis of cystic pancreatic tumors (CPTs)...
  33. ncbi Severe acute pancreatitis
    Vege Santhi Swaroop
    Division of General Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    JAMA 291:2865-8. 2004
  34. ncbi EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice
    Michael J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Gastrointest Endosc 61:467-72. 2005
    ..Doing so helps guide management and may help to avoid unnecessary surgery. Prospective studies are needed to verify these findings and to more clearly define the role of EUS TCB in these patients...
  35. ncbi Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas
    Thomas Schnelldorfer
    Division of Gastroenterologic and General Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Arch Surg 143:639-46; discussion 646. 2008
    ..Intraductal papillary mucinous neoplasm (IPMN) is an increasingly recognized disease of the pancreas. We report our experience with pancreatic resection for IPMN...
  36. ncbi Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis
    Mark Topazian
    Miles and Shirley Fiterman Center for Digestive Diseases, Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55906, USA
    Clin Gastroenterol Hepatol 6:364-6. 2008
    ..Biliary strictures occur in a third of patients with autoimmune pancreatitis and have been termed immunoglobulin G subclass 4 (IgG4) associated cholangitis (IAC). IAC often responds to steroid therapy...
  37. ncbi Endoscopic retrograde cholangiopancreatography-induced severe acute pancreatitis
    Santhi Swaroop Vege
    Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Pancreatology 6:527-30. 2006
    ..Compared to other causes, higher morbidity and mortality have been reported in ERCP-induced acute pancreatitis. We undertook this study to determine the differences between ESAP and SAP due to other causes (OSAP)...
  38. ncbi Outcomes of intra-abdominal fungal vs. bacterial infections in severe acute pancreatitis
    Santhi Swaroop Vege
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 104:2065-70. 2009
    ..We aimed to compare the morbidity and mortality of IFI compared with intra-abdominal bacterial infection (IBI) and no intra-abdominal infection (NII) in patients with SAP...
  39. ncbi Intraductal papillary mucinous neoplasm: did it exist prior to 1980?
    Matthew K Tollefson
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Pancreas 26:e55-8. 2003
    ..Intraductal papillary mucinous neoplasm (IPMN) of the pancreas was first reported in 1982. It is not clear whether the appearance of this neoplasm is a new epidemic or an old disease previously overlooked...
  40. ncbi Distinguishing pancreatic cancer from autoimmune pancreatitis
    Aravind Sugumar
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Curr Gastroenterol Rep 12:91-7. 2010
    ..The two strategies reflect differences in clinical practice and local preferences in the use of certain diagnostic tests. However, both strategies require thorough familiarity with the diseases and the tests being used...
  41. ncbi IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis
    Lizhi Zhang
    Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 34:88-94. 2010
    ..PSC with tissue IgG4 positivity has a more aggressive clinical course manifested by shorter time to transplant and a higher likelihood of recurrence than IgG4 negative PSC...
  42. ncbi Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience
    Suresh T Chari
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Clin Gastroenterol Hepatol 4:1010-6; quiz 934. 2006
    ..AIP has unique histologic features associated with infiltration of tissues of affected organs with abundant IgG4-positive cells. We propose expanded diagnostic criteria for AIP with a cohort of histologically confirmed AIP...
  43. ncbi Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings
    Naoki Takahashi
    Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Radiology 242:791-801. 2007
    ..To retrospectively evaluate computed tomographic (CT) and magnetic resonance (MR) imaging renal findings at clinical presentation, during treatment, and at follow-up in patients with autoimmune pancreatitis (AIP)...
  44. ncbi Treatment options for hepatobiliary and pancreatic cancer
    Steven R Alberts
    Division of Medical Oncology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 82:628-37. 2007
    ..For pancreatic cancer, surgery, radiation, and systemic therapy all have potential roles. This review provides an updated summary of diagnosis and assessment together with treatment options for this group of cancers...
  45. ncbi Chronic pancreatitis: focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis
    M J Levy
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Endoscopy 38:S30-5. 2006
  46. ncbi Inflammatory bowel disease in the setting of autoimmune pancreatitis
    Karthik Ravi
    Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Inflamm Bowel Dis 15:1326-30. 2009
    ..Despite scattered case reports, the prevalence of inflammatory bowel disease (IBD) in patients with autoimmune pancreatitis (AIP) is unknown. We sought to better characterize the putative association between the conditions...
  47. ncbi 75-year-old man with abdominal pain and weight loss
    Michael D Leise
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 83:1161-4. 2008
  48. ncbi Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection
    Dhiraj Yadav
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 1:129-35. 2003
    ..Resection of mass prevents recurrence of symptoms in idiopathic TCP...
  49. ncbi Eosinophilia and allergic disorders in autoimmune pancreatitis
    Raghuwansh P Sah
    Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Am J Gastroenterol 105:2485-91. 2010
    ..In autoimmune pancreatitis (AIP), the prevalence, interrelationships, and significance of peripheral eosinophilia, allergic disorders, and eosinophil infiltration in the pancreas remain unclear...
  50. ncbi New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
    Rahul Pannala
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, MN, USA
    Lancet Oncol 10:88-95. 2009
    ....
  51. ncbi Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings
    Kale D Bodily
    Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
    AJR Am J Roentgenol 192:431-7. 2009
    ..It is important for radiologists to understand both the pancreatic and extrapancreatic imaging findings of autoimmune pancreatitis to make accurate and timely diagnoses...
  52. ncbi Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis
    Raghuwansh P Sah
    Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 8:91-6. 2010
    ..We explored the clinical profiles and relationship between these diseases...
  53. ncbi Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology
    Bijayee Shrestha
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Am J Surg Pathol 33:1450-62. 2009
    ..The significance of increased IgG4+ cells in high proportion of RD cases merits further study as does overlap of RD and IgG4 disease...
  54. ncbi Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer
    Rahul Pannala
    Department of Gastroenterology and Hepatology, Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 104:2318-25. 2009
    ..Although the association between diabetes mellitus (DM) and pancreatic cancer is well described, temporal patterns of changes in fasting blood glucose (FBG) and body mass index (BMI) before pancreatic cancer diagnosis are not known...
  55. ncbi Acute pancreatitis in patients with Crohn's disease: clinical features and outcomes
    Picha Moolsintong
    Department of Internal Medicine and Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Inflamm Bowel Dis 11:1080-4. 2005
    ..A small proportion of patients remained idiopathic...
  56. ncbi Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus
    Rahul Pannala
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota
    Gastroenterology 134:981-7. 2008
    ..Information on the clinical profile of pancreatic cancer (PaC) associated diabetes (DM) is limited. We compared the prevalence and clinical characteristics of DM in subjects with and without PaC...
  57. ncbi Recent advances in autoimmune pancreatitis
    D H Park
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Gut 58:1680-9. 2009
    ..Recent development of animal models of AIP will help improve our understanding of the pathogenesis of these newly described forms of chronic pancreatitis...
  58. ncbi Endoscopic ultrasonography and pancreatic cancer
    T B Gardner
    Miles and Shirley Fiterman Centre for Digestive Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Minerva Gastroenterol Dietol 54:161-76. 2008
    ..Finally, exciting new developments suggest the potential of EUS as a therapeutic tool, both for the management of pain from pancreatic cancer and as a novel therapeutic-delivery device...
  59. ncbi Chronic pancreatitis: classification, relationship to acute pancreatitis, and early diagnosis
    Suresh T Chari
    Division of Gastroenterology and Hepatology, 200 First St SW, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Gastroenterol 42:58-9. 2007
  60. ncbi Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?
    Brian J Billings
    Department of Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Gastrointest Surg 9:1059-66; discussion 1066-7. 2005
    ..QoL after TP is decreased compared with age- and gender-matched controls but not with diabetes from other causes; however, the changes are not overwhelming. TP should remain a viable option but in selected patients...
  61. ncbi Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients
    Mario Pelaez-Luna
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 102:1759-64. 2007
    ..Among a cohort of patients with IPMN-Br we determined if the consensus IR (CIR), presence of multifocal IPMN-Br, or growth of cyst size on follow-up predict malignancy...
  62. ncbi Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies
    Aravind Sugumar
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55901, USA
    Clin Gastroenterol Hepatol 7:S59-62. 2009
    ..Additionally, differences in clinical practice and local preference in the use of certain diagnostic tests need to be considered while adopting either strategy...
  63. ncbi Autoimmune pancreatitis
    Timothy B Gardner
    Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Gastroenterol Clin North Am 37:439-60, vii. 2008
    ..Although still a rare disease, autoimmune pancreatitis is increasingly becoming recognized clinically, leading to evolution in the understanding of its prognosis, clinical characteristics, and treatment...
  64. ncbi Asymptomatic solid pseudopapillary neoplasm of the pancreas
    Ferga C Gleeson
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Clin Gastroenterol Hepatol 6:A22. 2008
  65. ncbi Optimising corticosteroid treatment for autoimmune pancreatitis
    Amaar Ghazale
    Division of Gastroenterology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gut 56:1650-2. 2007
  66. ncbi Long-term survival and prognostic indicators in small (<or=2 cm) pancreatic cancer
    Supot Pongprasobchai
    Division of Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA
    Pancreatology 8:587-92. 2008
    ..In a matched analysis, we investigated clinical, histopathological, and survival characteristics of small (<or=2 cm) pancreatic cancer (PaC) as compared to large PaC...
  67. ncbi Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature
    Einar Bjornsson
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    Hepatology 45:1547-54. 2007
  68. ncbi Conservative management of infected necrosis complicating severe acute pancreatitis
    Douglas G Adler
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55901, USA
    Am J Gastroenterol 98:98-103. 2003
    ..High risk necrosectomy can, in some instances, be delayed or avoided entirely...
  69. ncbi Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study
    Aravind Sugumar
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Gut 60:666-70. 2011
    ..Characteristic pancreatic duct changes on endoscopic retrograde pancreatography (ERP) have been described in autoimmune pancreatitis (AIP). The performance characteristics of ERP to diagnose AIP were determined...
  70. ncbi Natural history of endocrine failure in tropical chronic pancreatitis: a longitudinal follow-up study
    Viswanathan Mohan
    Madras Diabetes Research Foundation and Dr Mohans M V Diabetes Specialities Center, Gopalapuram, Chennai, India
    J Gastroenterol Hepatol 20:1927-34. 2005
    ..The aim of the present study was to determine the natural history of endocrine failure in TCP subjects without diabetes at baseline...
  71. ncbi Current concepts in the treatment of autoimmune pancreatitis
    Suresh T Chari
    JOP 8:1-3. 2007
    ..The inflammatory component of the disease appears to resolve with steroid treatment, though relapses do occur. Here we briefly discuss the role of steroid therapy in the management of autoimmune pancreatitis...
  72. ncbi Controversies in clinical pancreatology: management of acute idiopathic recurrent pancreatitis
    William M Steinberg
    Department of Medicine, George Washington University Medical Center, Washington, DC, USA
    Pancreas 27:103-17. 2003
  73. ncbi Can histopathology be the "Gold Standard" for diagnosing autoimmune pancreatitis?
    Suresh T Chari
    Gastroenterology 129:2118-20; discussion 2120. 2005
  74. ncbi Autoimmune pancreatitis, Part II: the relapse
    Suresh T Chari
    Gastroenterology 134:625-8. 2008
  75. ncbi Cyst fluid analysis to diagnose pancreatic cystic lesions: an as yet unfulfilled promise
    Mario Pelaez-Luna
    Gastroenterology 130:1007-9; discussion 1009. 2006
  76. ncbi Management of pancreatic masses
    Daniel Wolfson
    Department of Medicine, George Washington University Medical Center, Washington, DC, USA
    Pancreas 31:203-17. 2005
  77. ncbi Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis
    Sumana Gangi
    University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    AJR Am J Roentgenol 182:897-903. 2004
    ..Pancreatic duct dilatation and cutoff are early findings associated with the development of pancreatic cancer and can be detected on CT with a high degree of reproducibility...
  78. ncbi Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma
    Michael H Muders
    Department of Biochemistry and Molecular Biology, Mayo Clinic Cancer Center, Rochester, Minnesota 55905, USA
    Cancer Res 66:10264-8. 2006
    ..Taken together, our data suggest that GIPC is a central molecule for the stability of IGF-IR and could be a target for future therapy...
  79. ncbi Diagnosis of pancreatic cancer using serum proteomic profiling
    Sudeepa Bhattacharyya
    Center for Orthopaedic Research, Department of Orthopaedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA
    Neoplasia 6:674-86. 2004
    ..These results suggest that high-throughput proteomics profiling has the capacity to provide new biomarkers for the early detection and diagnosis of PCa...
  80. ncbi Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist?
    Randall K Pearson
    Department of Medicine, George Washington University Medical Center, Washington, DC, USA
    Pancreas 27:1-13. 2003
  81. ncbi Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation
    Andrei V Ougolkov
    Division of Oncology Research, Gastrointestinal Unit, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Clin Cancer Res 12:5074-81. 2006
    ....
  82. ncbi Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis
    Martin E Fernandez-Zapico
    Gastroenterology Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Cancer Cell 7:39-49. 2005
    ..Thus, the discovery of prooncogenic pathways regulated by Vav1 makes it an attractive target for therapeutic intervention...
  83. ncbi Defective DNA mismatch repair in long-term (> or =3 years) survivors with pancreatic cancer
    John T Maple
    Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Pancreatology 5:220-7; discussion 227-8. 2005
    ..To determine if long-term survival in pancreatic cancer could be attributed to defective DNA MMR, we ascertained its prevalence in 35 pancreatic cancer patients who survived > or =3 years after surgery...

Research Grants4

  1. Does Hyperglycemia Predict Pancreatic Cancer Diagnosis?
    Suresh Chari; Fiscal Year: 2006
    ..The research described in this application is 100% relevant to pancreatic cancer. ..